Hjem › Atopisk dermatitis (eczem) › New York
Atopisk dermatitis (eczem) kliniske forsøg i New York
16 studier for Atopisk dermatitis (eczem) søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- OptiSkin Medical, New York
- Equity Medical, LLC, The Bronx
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 72 · Alle køn · Opdateret 29. sep. 2026 · NCT06808477Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Brooklyn
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, New York
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07298395A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Montefiore - Jacobi Dermatology Clinic, The Bronx
- Montefiore - Clinical Research Center, The Bronx
- Montefiore - Greene Medical Arts Pavillion, The Bronx
- og 2 flere
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 25. sep. 2026 · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07003425Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
Rekrutterer
Alder 13 til 17 · Alle køn · Opdateret 8. sep. 2026 · NCT07746427A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Sadick Research Group, LLC, New York
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 6, Kew Gardens
- Inmagene Site 21, New York
- Inmagene Site 11, Woodbury
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901Skin Microbial Ecology in Atopic Dermatitis
- University of Rochester Medical Center, Rochester
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 13 og opefter · Alle køn · Opdateret 14. jul. 2026 · NCT04170244A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Equity Medical /ID# 265814, New York
- Weill Cornell Medicine /ID# 265793, New York
RekruttererFase 3
Alder 18 til 63 · Alle køn · Opdateret 6. jul. 2026 · NCT06389136Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
- University of Rochester Medical Center: Department of Dermatology, Rochester
RekruttererFase 1
Alder 6 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT06504160A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Empire Dermatology, East Syracuse
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 4. maj 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site - Site 7080, Auburn
- Galderma Investigational Site # 7052, East Syracuse
- Galderma Investigational Site - 8282, Mount Kisco
- og 3 flere
RekruttererObservationsstudie
Alder 12 og opefter · Alle køn · Opdateret 13. mar. 2026 · NCT06988605Allergy and Immunology Natural History Study
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Op til 99 år · Alle køn · Opdateret 4. feb. 2026 · NCT05584488Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Icahn School of Medicine at Mount Sinai, New York
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 2. feb. 2026 · NCT07242638A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
- Pfizer, New York
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 0 og opefter · Kvinder · Opdateret 9. dec. 2025 · NCT05721937Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.